The global Toxicology Testing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (Cell culture technology, High throughput technology, Molecular imaging, OMICS technology), By End-User (Pharmaceutical industry, Food industry, Others).
The Toxicology Testing Market includes toxicology assays, in vitro toxicology tests, drug toxicity screening, and toxicology testing services used in pharmaceutical research, environmental monitoring, and toxicological evaluations for assessing chemical hazards, drug safety profiles, and environmental toxins. Toxicology testing methods involve cell-based assays, animal studies, and human biomonitoring techniques for toxicity assessment, carcinogenicity testing, and hazard identification in chemicals, pharmaceuticals, consumer products, and environmental samples. Market dynamics encompass toxicology testing platforms, high-throughput screening assays, regulatory toxicology requirements, and toxicogenomics approaches for comprehensive toxicological risk assessment and safety evaluations.
The global Toxicology Testing Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Toxicology Testing Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Toxicology Testing Industry include- BICO Group AB, Bio Rad Laboratories Inc, BioIVT LLC, Catalent Inc, Charles River Laboratories, CompuDrug Ltd, Eurofins Scientific SE, Evotec SE, Ingenza Ltd, Laboratory Corp of America Holdings, Merck KGaA, PerkinElmer Inc, Quest Diagnostics Inc, Randox Laboratories Ltd, Thermo Fisher Scientific Inc.
Toxicology testing market observes a trend towards a shift towards high-throughput screening methods. With the aim of improving efficiency, scalability, and cost-effectiveness, there's increasing interest in adopting automated and multiplexed assay platforms for toxicological assessments. Additionally, advancements in cell-based assays, organ-on-a-chip technologies, and in silico modeling enable comprehensive evaluation of chemical hazards, drug toxicity, and environmental risks, facilitating faster decision-making in drug development, chemical safety, and regulatory compliance.
The primary driver for the toxicology testing market is the stringent regulatory requirements for safety assessment in pharmaceutical, chemical, and consumer product industries. Regulatory agencies mandate thorough toxicological evaluations to assess the potential risks associated with exposure to drugs, chemicals, food additives, and environmental pollutants. Toxicology testing plays a crucial role in identifying and characterizing toxic effects, establishing safe exposure limits, and ensuring product safety for human health and the environment, thereby driving the demand for toxicology testing services and technologies.
An opportunity exists in the expansion into personalized and precision toxicology approaches. Companies investing in the development of personalized toxicology testing services and precision medicine strategies can address individual variability in drug response, susceptibility to chemical exposures, and environmental sensitivities. By integrating genomic, transcriptomic, and metabolomic data into toxicological assessments, stakeholders can identify biomarkers of toxicity, predict individualized risk profiles, and tailor risk management strategies to optimize patient safety and environmental protection, ultimately advancing the field towards personalized toxicology and precision risk assessment.
High throughput technology is experiencing the most rapid growth within toxicology testing, particularly in the pharmaceutical industry. High throughput screening (HTS) allows for the rapid analysis of a large number of compounds or samples, enabling pharmaceutical companies to efficiently assess the toxicity and safety profiles of drug candidates. With the ever-increasing number of potential therapeutic compounds being developed, there is a growing need for robust and high-throughput toxicology testing methods to expedite the drug discovery and development process. High throughput technology offers advantages such as automation, miniaturization, and the ability to generate large datasets quickly, allowing researchers to screen thousands of compounds for toxicity in a fraction of the time compared to traditional methods. Additionally, HTS techniques provide valuable insights into compound interactions and mechanisms of toxicity, aiding in the identification of lead compounds and the optimization of drug candidates. As pharmaceutical companies strive to bring safe and effective drugs to market efficiently, the demand for high throughput technology in toxicology testing is expected to continue its rapid growth trajectory, driving advancements in drug discovery and safety assessment.
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
BICO Group AB
Bio Rad Laboratories Inc
BioIVT LLC
Catalent Inc
Charles River Laboratories
CompuDrug Ltd
Eurofins Scientific SE
Evotec SE
Ingenza Ltd
Laboratory Corp of America Holdings
Merck KGaA
PerkinElmer Inc
Quest Diagnostics Inc
Randox Laboratories Ltd
Thermo Fisher Scientific Inc
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Toxicology Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Toxicology Testing Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Toxicology Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Toxicology Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Toxicology Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Toxicology Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Toxicology Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Toxicology Testing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Toxicology Testing Industry
4.2 Key Market Trends in Toxicology Testing Industry
4.3 Potential Opportunities in Toxicology Testing Industry
4.4 Key Challenges in Toxicology Testing Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Toxicology Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Toxicology Testing Market Outlook by Segments
7.1 Toxicology Testing Market Outlook by Segments, $ Million, 2021- 2030
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
8 North America Toxicology Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Toxicology Testing Markets in 2024
8.2 North America Toxicology Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
9 Europe Toxicology Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Toxicology Testing Markets in 2024
9.2 Europe Toxicology Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Toxicology Testing Market Size Outlook by Segments, 2021-2030
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
10 Asia Pacific Toxicology Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Toxicology Testing Markets in 2024
10.2 Asia Pacific Toxicology Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
11 South America Toxicology Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Toxicology Testing Markets in 2024
11.2 South America Toxicology Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
12 Middle East and Africa Toxicology Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Toxicology Testing Markets in 2024
12.2 Middle East and Africa Toxicology Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Toxicology Testing Market size Outlook by Segments, 2021-2030
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
BICO Group AB
Bio Rad Laboratories Inc
BioIVT LLC
Catalent Inc
Charles River Laboratories
CompuDrug Ltd
Eurofins Scientific SE
Evotec SE
Ingenza Ltd
Laboratory Corp of America Holdings
Merck KGaA
PerkinElmer Inc
Quest Diagnostics Inc
Randox Laboratories Ltd
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Technology
Cell culture technology
High throughput technology
Molecular imaging
OMICS technology
By End-User
Pharmaceutical industry
Food industry
Others
The global Toxicology Testing Market is one of the lucrative growth markets, poised to register a 14.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BICO Group AB, Bio Rad Laboratories Inc, BioIVT LLC, Catalent Inc, Charles River Laboratories, CompuDrug Ltd, Eurofins Scientific SE, Evotec SE, Ingenza Ltd, Laboratory Corp of America Holdings, Merck KGaA, PerkinElmer Inc, Quest Diagnostics Inc, Randox Laboratories Ltd, Thermo Fisher Scientific Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume